ACM Research Inc

ACMR’s medium-term bias is Bearish within a Stage 4 declining downtrend, characterized by sequential lower highs and lower lows trading beneath the falling short- and mid-term EMAs. The tradable side is to sell into pullbacks at these moving-average-resistance zones. Price is currently testing the EMAs, offering a sell entry, with short-term timing conditions favoring execution now. The long-term uptrend remains intact above the rising 200-day SMA.

• ↑Q2 revenue up 36% YoY to $293M driven by 150%+ advanced packaging growth
• ↑Raised 2026 revenue guidance to $1.125–$1.175B, implying 25–30% growth
• ↓Negative earnings yield and GF Value imply ~98% downside risk